Acta Psychiatr Scand

1. MUSTONEN A, Niemela S, Denissoff A, Tanskanen A, et al
   Comparative Clinical Trajectories Across Cannabis-Related and Nonsubstance-Related Psychoses.
   Acta Psychiatr Scand. 2026 Apr 8. doi: 10.1111/acps.70097.
   

   >> Share

   
   
2. KOUGIANOU I, Talukder A, Hare KO, Healy C, et al
   Selective Serotonin Reuptake Inhibitor Treatment in Adolescence and Subsequent Risk of Nonaffective Psychosis: A Quasi-Experimental Study.
   Acta Psychiatr Scand. 2026 Apr 7. doi: 10.1111/acps.70098.
   

   >> Share

   
   
3. SERRA-NAVARRO M, Heilbronner M, Sole B, Borras R, et al
   Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study.
   Acta Psychiatr Scand. 2026;153:449-467.
   

   >> Share

   
   

   
   Addict Behav

4. RICCI V, Martinotti G, Maina G
   The role of hopelessness and depression in cannabis-induced first-episode psychosis: a 24-month prospective study.
   Addict Behav. 2026;179:108699.
   

   >> Share

   
   

   
   Can J Psychiatry

5. LU Y, Todesco B, Hawke LD, Kozloff N, et al
   Optimizing Health for Canadian Youth at Clinical High Risk for Psychosis: A Feasibility Study: Optimiser la sante des jeunes Canadiens presentant un risque clinique eleve de psychose : Une etude de faisabilite.
   Can J Psychiatry. 2026 Apr 7:7067437261436536. doi: 10.1177/07067437261436536.
   

   >> Share

   
   

   
   J Clin Psychiatry

6. MCINTYRE RS, Matthews DM, Arevalo C, McDonnell D, et al
   The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia.
   J Clin Psychiatry. 2026;87:25m16170.
   

   >> Share

   
   

   
   Mol Psychiatry

7. YANG X, Agartz I, Andreassen O, Bachman P, et al
   Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis.
   Mol Psychiatry. 2026 Apr 4. doi: 10.1038/s41380-026-03586.
   

   >> Share

   
   

   
   Psychiatry Res

8. TANG W, Guan C, Ling Z, Zhang X, et al
   Development of a risk prediction model for relapse in patients with schizophrenia based on a systematic review and meta-analysis.
   Psychiatry Res. 2026;361:117106.
   

   >> Share

   
   
9. DANIEL DTG, Choi JJ, Aluri J, McCaulley C, et al
   Qualitative analysis of long-term clozapine adherence in schizophrenia: An exploratory study.
   Psychiatry Res. 2026;361:117136.
   

   >> Share

   
   
10. OKA S, Yamazaki T, Takefuji Y
    Breaking the spline: Why distributed lag non-linear models miss thresholds in environmental psychiatry.
    Psychiatry Res. 2026;360:117104.
    

    >> Share

    
    
11. XIAO D, Zhu C
    The role of serum BDNF levels in cognitive dysfunction among psychiatric disorders.
    Psychiatry Res. 2026;360:117069.
    

    >> Share

    
    

    
    Psychol Med

12. MONISTROL-MULA A, Felez-Nobrega M, Byrne EM, Lind PA, et al
    The effect of polygenic liability to mental disorders on COVID-19 outcomes in people with depression: the mediating role of anxiety.
    Psychol Med. 2024;54:4140-4149.
    

    >> Share

    
    
13. YILDIRIM B, Sahin SS, Gee A, Jauhar S, et al
    Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports.
    Psychol Med. 2024;54:4035-4047.
    

    >> Share

    
    
14. KENDLER KS, Henrik O, Sundquist J, Sundquist K, et al
    Age at onset as an index of genetic heterogeneity in major psychiatric and substance use disorders.
    Psychol Med. 2024;54:4335-4347.
    

    >> Share

    
    
15. AFTAB A
    Making sense of the literature on antipsychotics and long-term functioning: taking natural history and personalization seriously.
    Psychol Med. 2024;54:4485-4492.
    

    >> Share

    
    
16. HUANG D, Liu Z, Tan W, Sopodenkiewicz M, et al
    Dynamic frontoparietal flexibility and cognitive dysfunction in schizophrenia: disentangling the roles of symptom burden and childhood trauma.
    Psychol Med. 2026;56:e93.
    

    >> Share

    
    
17. LU ZA, Ploner A, Bergen SE
    Joint effects of childhood adversity and genetic risk for psychosis on psychopathology in the UK Biobank.
    Psychol Med. 2026;56:e92.
    

    >> Share

    
    
18. HUANG H, Sun Y, Yin J, An S, et al
    Inflammatory cytokine alterations in genetic and clinical high risk groups of psychosis: a systematic review and network meta-analysis.
    Psychol Med. 2026;56:e99.
    

    >> Share

    
    
19. O'MAHONY BW, Burke T, Hamill R, Gannon L, et al
    Interventions to prevent antipsychotic-induced weight gain and metabolic complications in individuals with a first-episode psychosis and minimal antipsychotic exposure: a systematic review and meta-analysis.
    Psychol Med. 2026;56:e101.
    

    >> Share

    
    

    
    Schizophr Res

20. KU BS, Arrant EJ, Yuan QE, Aberizk KM, et al
    Social withdrawal and hippocampal volume among adolescents at clinical high risk for psychosis and healthy comparisons: The moderating role of neighborhood residential stability.
    Schizophr Res. 2026;293:81-90.
    

    >> Share

    
    
21. GAO Y, Yan H, Hu R, Liu S, et al
    Effect of transcranial alternating current stimulation on auditory verbal hallucinations in patients with treatment-resistant schizophrenia.
    Schizophr Res. 2026;293:72-80.
    

    >> Share

    
    
22. OH H, Goncalves CC, Arend JL, Blosnich JR, et al
    Sexual and gender minorities and psychosis research.
    Schizophr Res. 2026;293:67-68.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share